Post translational activation of latent transforming growth factor beta (L-TGF-β): Clinical implications

Histology and Histopathology

Volumn 16, Issue 2, 2001, Pages 541-551

  Khalil, N ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

v 6; CD36; Fibrosis; Latency associated protein; Latent TGF ; Latent TGF binding protein; M 6 P IGF II R; Plasmin; Thrombospondin 1

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANGIOTENSIN; CD36 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTEGRIN; MANNOSE 6 PHOSPHATE; PLASMIN; PLASMINOGEN; PROTEIN PRECURSOR; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN RECEPTOR; TAURINE; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

CELL MEMBRANE; CONNECTIVE TISSUE DISEASE; CYTOKINE PRODUCTION; DRUG EFFECT; FIBROSIS; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; LATENT PERIOD; NONHUMAN; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; TISSUE METABOLISM;

ANIMALS; BIOTRANSFORMATION; CARRIER PROTEINS; CELL MEMBRANE; CONNECTIVE TISSUE DISEASES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LATENT TGF-BETA BINDING PROTEINS; PEPTIDE FRAGMENTS; PLASMIN; PROTEIN CONFORMATION; PROTEIN ISOFORMS; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

MAMMALIA;

EID: 0035065928     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. The plasminogen activation inhibitor system in bone cell function
2. An activated form of transforming growth factor-β is produced by co-cultures of endothelial cells and pericytes
3. Transforming growth factor-beta activation in irradiated murine mammary gland
4. Redox-mediated activation of latent transforming growth factor-β1
5. Immunohistochemical detection of active transforming growth factor-β in situ using engineered tissue
6. Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation
7. Regulation and regulatory activities of transforming growth factor-β
8. Transforming growth factor beta in tissue fibrosis
9. Interactions of transforming growth factor-β and angiotensin-II in renal fibrosis
10. Future trends in the treatment of rheumatoid arhtritis: Cytokine targets
11. Physiological activation of recombinant latent transforming growth factor-βs 1,2,3
12. Site directed mutagenesis of cysteine residues in the pro region of the transforming growth factor-β1 precursor. Expression and characterization of mutant proteins
13. Glucocorticoidss induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor-β
14. Thrombospondin-1 is a major activator of TGF-β1
15. Cellular activation of latent transforming growth factor-β requires binding to the cation-independent mannose-6-phosphate/insulin-like growth factor type II receptor
16. Processing of transforming growth factor-β1 precursor by human furin convertase
17. Bleomycin induced pulmonary fibrosis in transgenic mice that either lack or over express the murine plasminogen activator inhibitor-1 gene
18. Increased expression of transforming growth factor-beta 1 and thrombospondin-1 in congenital hepatic fibrosis: Possible role of hepatic stellate cell
19. Active and latent forms of transforming growth factor-β activity in synovial effusions
20. Role of latent TGF-β binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells
21. The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis
22. Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in pathogenesis
23. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-1
24. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein (a) mice
25. Transforming growth factor-beta: The key to understanding lipoprotein (a)
26. Role of transforming growth factor-β in tissue injury and repair
27. Regulation of plasminogen activator activity in arthritic joints
28. Lipoprotein (a), plasmin modulation and atherogenesis
29. Involvement of uPA in the antiapoptotic activity of TGF-β for vascular smooth muscle cells
30. Tyrosine kinase dependent expression of TGF-β induced by stretch in mesangial cells
31. Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration
32. Anti-latent TGF-beta binding protein-1 antibody or synthetic oligopeptides inhibit extracellular matrix expression induced by stretch in cultured rat mesangial cells
33. Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat
34. Activation of mesangial cell signaling cascades in response to mechanical strain
35. Complimentary dioxyribonucleic acid cloning in a messenger ribonucleic acid encoding transforming growth factor-beta4 from chicken embryo chondrocytes
36. Regulation of mannos-6-phosphate/insulin-like growth factor-II receptors and transforming growth factor-beta during liver tumor promotion with phenobarbital
37. Angiotensin-II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells
38. Regulation of the transforming growth factor-beta2 gene promoter in embryonal carcinoma cells and their differentiated cells: Differential utilization of transcription factors
39. TGF-β: From latent to active
40. Plasmin regulates the activation of cell associated latent TGF-β1 secreted by rat alveolar macrophages after in vivo bleomycin injury
41. After bleomycin induced lung injury regenerating alveolar epithelium has decreased expression of transforming growth factor-beta (TGF-β) receptors
42. Role of vitamin A in liver fibrosis
43. Mechanism of retinoid-induced activation of latent transforming growth factor-β in bovine endothelial cells
44. Identification of a novel transforming growth factor-beta (TGF-beta5) mRNA in Xenopus laevis
45. Interations of recombinant and platelet transforming growth factor-beta 1 precursor with the insulin-like growth factor II/mannose-6-phosphate receptor
46. Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and death
47. The evolution of the thrombospondin gene family
48. Regulation of the immune responses by TGF-β
49. Pathophysiology of the plasminogen/plasmin system
50. CD36 peptide enhance or inhibit CD36 thrombospondin binding: A two-step process of ligand receptor interaction
51. Proteolytic activation of latent transforming growth factor-β in fibroblast conditioned media
52. Structural characterization of the latent complex between transforming growth factor-beta1 and beta-1 latency associated peptide
53. A role of the latent TGF-beta 1 binding protein and assembly in the secretion of TGF-beta 1
54. Association of TGF-β signaling in angiotensin-II induced PAI-1 mRNA upregulation in mesangial cells: Role of PKC
55. The integrin αvβ6 binds and activates latent TGF-β1: A mechanism for regulation of pulmonary inflammation and fibrosis
56. Latent transforming growth factor-β binding proteins domains involved in activation and transglutaminase dependent cross-linking of latent transforming growth factor-β
57. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-β in liver stellate cells
58. Dual role for the latent transforming growth factro-β binding protein in storage of latent TGF-β in the extracellular matrix and as a structural matrix protein
59. Identification of mannose-6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-β1 precursor
60. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis
61. The activation sequence of thrombospondin-1 interacts with the latency associated peptide to regulate activation of latent transforming growth factor-β
62. Proteolytic control of growth factor availability
63. Molecular and cell biology of TGF-beta
64. Mechanistic interrelaltionships between two superfamilies: The steroid/retinoid receptors and transforming growth factor-β
65. Association of small latent transforming growth factor-β with an eight cysteine repeat of its bindings protein LTBP-1
66. Transforming growth factor-beta1 and mannose-6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat
67. The mechanism of activation of latent TGF-β during co-cultures of endothelial cells and smooth muscle cells: Cell type specific targeting of latent TGF-β to smooth muscle cells
68. Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: A self regulating system
69. Regulation of transforming growth factor-β activation by discrete sequence of thrombospondin-1
70. TGF-β receptors: A complicated system of multiple binding proteins
71. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-β as a key mediator
72. Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells
73. Transforming growth factor-beta receptors and mannose-6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma
74. The fibronectin production is increased by thrombospondin via activation of TGF-β in cultured human mesangial cells
75. Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein
76. Latent transforming growth factor-β1 and its binding proteins are components if extracellular matrix microfibrils
77. Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucoss, not by antiotensin-II
78. Latent transforming growth factor-β from human platelets: A high molecular weight complex containing precursor sequences
79. Transforming growth factor-β and urokinase plasminogen activation presents at endothelial cell-pericyte interdigitation in human granulation tissue
80. Upregulation and spatial shift in the localization of the mannose-6-phosphate/insulin-like growth factor-II receptor during radiation interopathy development in the rat
81. The role of angiotensin-II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms
82. Molecular mechanisms of diabetic renal hypertophy
83. A CD36 synthetic peptide inhibits bleomycin induced pulmonary inflammation and connective tissue synthesis in the rat
84. Activation of rat alveolar macrophage derived L-TGF-β1 by plasmin requires interaction with TSP-1 and the TSP-1 cell surface receptor, CD36
85. Transforming growth factor-β1 modulates β1 and β5 integrin receptors and induces the de novo expression of a αvβ6 heterodimer in normal human keritinocytes: Implications for wound healing